Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 12 Sep 2016  |  North America  |  Market Research

    Price Point Analysis for Laboratory Developed Tests (LDTs) and FDA Regulated Tests

    Discover the Perfect Assay Price Point to Remain Competitive

    The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

    MYR7,153.80
  2. 12 Sep 2016  |  North America  |  Market Research

    Analysis of US Food Intolerance and Allergy Testing Market

    Explore Potential Partners and Distribution Channels to Increase Market Position in the Direct-to-Consumer Pathway

    The objective of this research is to understand the food intolerance and food allergy testing market in the United States. While allergy testing is common, food intolerance testing is provided by very few manufacturers, mostly as laboratory developed tests (LDTs) in the direct-to-consumer (DTC) pathway. The study includes key profiles of food intol...

    MYR7,153.80
  3. 08 Sep 2016  |  Global  |  Market Research

    Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies

    Big Data Initiatives Targeted at Health Prediction and Precision

    The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...

    MYR7,153.80
  4. 06 Sep 2016  |  North America  |  Market Research

    Analysis of Alphabet, Google, and Healthcare

    Is Alphabet Poised to Disrupt the Healthcare Industry?

    Healthcare is a vertical ripe with growth opportunities across the industry landscape, driving interest from stakeholders and vendors trying to leverage it as a center for innovation. Large vendors from the tech side, including Alphabet, Amazon, Samsung, Apple, and Salesforce, are all refining and pushing their healthcare sector value proposition i...

    MYR7,153.80
  5. 31 Aug 2016  |  North America  |  Market Research

    Augmented and Virtual Reality Applications in Healthcare

    Novel Platforms Enable Innovative Healthcare Applications and Business Models

    The Augmented Reality (AR) market, although in its early stages, has been growing rapidly since the last two years. The next 5 years will produce diverse AR content from varied fields and industries and affordable solutions for consumers. AR enterprise applications and subsequent subscription models will boost revenue for start-up companies in this...

    MYR7,153.80
  6. 25 Jul 2016  |  Asia Pacific  |  Market Research

    Intracranial Flow Diverters in 2016 and Beyond

    Developing the Next-generation Aneurysm Treatment Devices

    Intracranial aneurysm (IA) is the enlargement of the arterial wall inside the skull that causes massive discomfort and can eventually rupture, leading to paralysis and fatality. Flow diverters, are intravascular divert pressure from a weakened wall of a blood vessel to provide long-term occlusion of the aneurysm and restore the vessel’s natural c...

    MYR7,153.80
  7. 15 Jul 2016  |  Europe  |  Market Research

    Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe

    Sector Convergence is Generating Growth Opportunities Across the Value Chain

    Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...

    MYR7,153.80
  8. 08 Jul 2016  |  North America  |  Market Research

    Digital Health Grows Up- Is Pharma Guiding the Way?

    Frost & Sullivan reviews key themes and industry trends from the 5th Annual Digital Health Summer Summit and BIO International held in June 2016. Major topics covered include the use of virtual and augmented reality in medical education and clinical care; new digital health technologies to improve mental health; investor perspectives on the market ...

    MYR7,153.80
  9. 30 Jun 2016  |  Global  |  Market Research

    Growth and Expansion of Regenerative Medicine Market

     

    The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments su...

    MYR7,153.80
  10. 30 Jun 2016  |  Global  |  Market Research

    Global Immunoglobulin Therapeutics Market

     

    Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...

    MYR7,153.80